MCL1 and metabolic dysfunction-associated steatohepatitis: More recently, Mcl-1 deficiency in the liver was shown to exacerbate the non-alcoholic steatohepatitis (NASH) phenotype with progression to liver cirrhosis and/or liver tumor in an obesity induced NASH model (Hirsova et al., 2020).